StonvexLoading…
StonvexStonvexStonvexCore line items from FSV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.50B | $5.22B | $4.33B | $3.75B |
Operating Income | $338.08M | $337.51M | $244.89M | $219.03M |
Net Income | $190.75M | $187.77M | $147.02M | $145.01M |
EPS (Diluted) | $3.17 | $2.97 | $2.24 | $2.72 |
Total Assets | $4.28B | $4.19B | $3.63B | $2.77B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $154.43M | $227.60M | $187.62M | $136.22M |
Free Cash Flow OCF − CapEx | $318.24M | $172.88M | $187.63M | $28.28M |
Shares Outstanding | 45.72M | 45.27M | 44.68M | 44.23M |